When the Agency’s Risk Assessment Committee (‘RAC’) assessed the proposal of a restriction to the placing on the market and use of D4 and D5 that was ultimately adopted in Regulation (EU) 2018/35, it did not exclude a potential risk from their use in leave-on cosmetic products. For this reason, on 15 December 2016, the Commission requested [https://echa.europa.eu/documents/10162/13641/echa_commission_request_en.pdf/a0bdbb25-9641-9df1-9511-4208cac224ce.] the Agency to prepare a dossier pursuant to Article 69(1) of Regulation (EC) No 1907/2006 (the ‘Annex XV dossier’), with a view to a potential restriction of D4 and D5 in leave-on cosmetic products and other consumer and professional products. On 5 February 2018, the Commission requested [https://echa.europa.eu/documents/10162/13641/note_to_echa_annex_xv_d6_en.pdf/722217b2-95c1-a5a0-90c5-82f2afed48f9.] the Agency to include D6 in the Annex XV dossier.
Recital 3, Regulation (EU) 2024/1328
In forcesince 16 May 2024
Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 Decembe…69Law
- num:eu=2018/35 (several documents carry this name)